• Personalized tumor vaccine shows promise in pilot trial

    11 monthes ago - By ScienceDaily

    A new type of cancer vaccine has yielded promising results in an initial clinical trial. The personalized vaccine is made from patients' own immune cells, which are exposed to the contents of the patients' tumor cells, and injected into the patients to initiate a wider immune response. The trial, conducted in advanced ovarian cancer patients, showed that about half of the vaccinated patients had signs of anti-tumor T-cell responses.
    Read more ...


  • Liquid biopsy platforms yield different results for identical tumor samples

    11 monthes ago - By Healio

    Gonzalo Torga Kenneth Pienta
    Two commercial liquid biopsy platforms that evaluated identical tumor samples reported significantly different results, according to study findings.
    Gonzalo Torga, MD, postdoctoral research fellow at Brady Urological Institute at Johns Hopkins, and Kenneth Pienta, MD, director of research and prostate cancer researcher at Brady Urological Institute and medical oncologist at Johns Hopkins Kimmel Cancer Center, sent identical samples from 40 men with prostate cancer for analysis by the Guardant360 and PlasmaSELECT
    Read more ...